Tiaa, Fsb Astrazeneca PLC Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Astrazeneca PLC stock. As of the latest transaction made, Tiaa, Fsb holds 14,601 shares of AZN stock, worth $923,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,601

Previous 15,007 2.71%

Holding current value

$923,221

Previous $1.04 Million 0.29%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$69.91 - $75.81 $28,383 - $30,778	-406 Reduced 2.71%	14,601 $1.04 Million
Q1 2023 Apr 19, 2023	BUY	$63.15 - $71.6 $16,229 - $18,401	257 Added 1.74%	15,007 $1.04 Million
Q4 2022 Jan 12, 2023	SELL	$54.21 - $70.44 $22,551 - $29,303	-416 Reduced 2.74%	14,750 $1 Million
Q3 2022 Oct 11, 2022	SELL	$53.02 - $135.75 $71,470 - $182,991	-1,348 Reduced 8.16%	15,166 $832,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $132,209 - $158,713	-2,231 Reduced 11.9%	16,514 $1.09 Million
Q1 2022 Apr 13, 2022	SELL	$55.72 - $67.12 $280,215 - $337,546	-5,029 Reduced 21.15%	18,745 $1.03 Million
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $76,492 - $90,383	-1,416 Reduced 5.62%	23,774 $1.19 Million
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $192,793 - $210,941	3,470 Added 15.98%	25,190 $1.51 Million
Q2 2021 Jul 21, 2021	SELL	$48.42 - $60.18 $36,557 - $45,435	-755 Reduced 3.36%	21,720 $1.3 Million
Q1 2021 Apr 21, 2021	SELL	$47.16 - $54.44 $242,496 - $279,930	-5,142 Reduced 18.62%	22,475 $1.12 Million
Q4 2020 Jan 21, 2021	SELL	$48.52 - $58.02 $102,183 - $122,190	-2,106 Reduced 7.09%	27,617 $1.38 Million
Q3 2020 Oct 13, 2020	SELL	$53.07 - $61.1 $267,791 - $308,310	-5,046 Reduced 14.51%	29,723 $1.63 Million
Q2 2020 Jul 15, 2020	BUY	$43.1 - $55.31 $556,722 - $714,439	12,917 Added 59.11%	34,769 $1.84 Million
Q1 2020 Apr 21, 2020	SELL	$37.79 - $51.33 $59,708 - $81,101	-1,580 Reduced 6.74%	21,852 $977,000
Q4 2019 Jan 13, 2020	SELL	$42.46 - $50.46 $239,983 - $285,199	-5,652 Reduced 19.43%	23,432 $1.17 Million
Q3 2019 Oct 08, 2019	SELL	$40.12 - $45.47 $107,401 - $121,723	-2,677 Reduced 8.43%	29,084 $1.3 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $15,993 - $17,880	-429 Reduced 1.33%	31,761 $1.31 Million
Q1 2019 Apr 15, 2019	SELL	$35.49 - $43.02 $9.5 Million - $11.5 Million	-267,789 Reduced 89.27%	32,190 $1.3 Million
Q4 2018 Apr 15, 2019	BUY	$36.86 - $41.49 $11.1 Million - $12.4 Million	299,979 New	299,979 $11.4 Million
Q4 2018 Feb 22, 2019	SELL	$36.86 - $41.49 $13.7 Million - $15.4 Million	-370,948 Closed	0 $0
Q3 2018 Oct 18, 2018	SELL	$34.76 - $39.72 $1.06 Million - $1.21 Million	-30,488 Reduced 7.59%	370,948 $14.7 Million
Q2 2018 Jul 20, 2018	BUY	$34.55 - $37.05 $5.09 Million - $5.46 Million	147,433 Added 58.04%	401,436 $14.1 Million
Q1 2018 Apr 18, 2018	BUY	$32.97 - $36.63 $7.48 Million - $8.31 Million	226,916 Added 837.73%	254,003 $8.88 Million
Q4 2017 Jan 29, 2018	BUY	$32.09 - $34.78 $54,296 - $58,847	1,692 Added 6.66%	27,087 $940,000
Q3 2017 Oct 24, 2017	BUY	$28.96 - $34.0 $735,439 - $863,430	25,395	25,395 $860,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account